文献速递乳腺乳腺X线US

仅由数字乳腺断层摄影检出且超声无对应病灶、空心针活检非恶性的结构扭曲:以影像为重点的管理策略结局

Architectural Distortions Detected by DBT Alone With No Ultrasound Correlate and Nonmalignant Results on Core Needle Biopsy: Outcomes From an Imaging-Focused Management Strategy.
PubMed 文献 · AJR Am J Roentgenol · 2025-03-12

回顾性研究纳入2020年7月1日至2023年12月31日仅由DBT检出、超声无对应病灶且立体定向空心针活检(12条9G真空辅助针)非恶性的结构扭曲109处(106例患者,平均年龄58岁)。活检良性者恶性率0%(0/58),无 atypia 的放射状瘢痕0%(0/36),伴 atypia 的放射状瘢痕10%(1/10),不伴放射状瘢痕的 atypia 40%(2/5);总体活检无 atypia 者恶性率0%(0/94),有 atypia 者20%(3/15)。结论认为无 atypia 的结构扭曲恶性率为0%,影像随访可能是手术切除的安全替代。

要点

  • 仅DBT检出、超声无对应病灶且CNB无 atypia 的结构扭曲恶性率为0%(0/94)。
  • CNB有 atypia(伴或不伴放射状瘢痕)的结构扭曲恶性率为20%(3/15)。
  • CNB良性或无 atypia 放射状瘢痕者建议6个月和12个月诊断性影像随访后再恢复年度筛查。

核心结论

  • CNB无 atypia 的结构扭曲恶性率为0%,有 atypia 者为20%。
  • 影像随访可能是仅DBT检出、超声无对应病灶且CNB良性无 atypia 的结构扭曲替代手术切除的安全选择。

研究设计与样本

  • 回顾性研究,纳入2020年7月1日至2023年12月31日仅由DBT检出、超声无对应病灶且立体定向CNB(12条9G真空辅助针)非恶性的结构扭曲。
  • 最终样本106例患者(平均年龄58岁)共109处结构扭曲,均接受重复CNB、手术切除或12个月诊断性影像随访。

诊断标准与关键数值

  • CNB良性病理的结构扭曲恶性率为0%(0/58),其中49处影像随访、2处重复CNB、7处切除。
  • CNB无 atypia 放射状瘢痕的恶性率为0%(0/36),其中22处影像随访、14处切除。
  • CNB伴 atypia 放射状瘢痕的恶性率为10%(1/10),均行切除。
  • CNB不伴放射状瘢痕的 atypia 恶性率为40%(2/5),其中2处影像随访、3处切除。
  • 总体CNB无 atypia 者恶性率0%(0/94),有 atypia(伴或不伴放射状瘢痕)者20%(3/15)。

临床应用与阅片要点

  • CNB良性病理或无 atypia 放射状瘢痕的结构扭曲建议行6个月和12个月诊断性影像随访后再恢复年度筛查,但患者可选择替代管理方案。
  • CNB有 atypia(伴或不伴放射状瘢痕)的结构扭曲建议行手术切除。
  • 作者认为影像随访可能是仅DBT检出、超声无对应病灶且CNB良性无 atypia 的结构扭曲替代手术切除的安全选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Architectural distortions (ADs) detected on digital breast tomosynthesis (DBT) are more frequently associated with nonmalignant pathologies than those detected on digital mammography. OBJECTIVE. The purpose of this study was to evaluate outcomes of ADs detected by DBT alone with no ultrasound correlate and nonmalignant results on core needle biopsy (CNB) when adopting a management strategy selectively incorporating imaging surveillance. METHODS. This retrospective study included patients with ADs detected by DBT alone with no ultrasound correlate and nonmalignant results on stereotactic CNB with 12 vacuum-assisted 9-gauge cores from July 1, 2020, to December 31, 2023. ADs detected by DBT alone with no ultrasound correlate showing concordant benign pathology or radial scar without atypia on CNB were recommended to undergo 6- and 12-month diagnostic imaging follow-up before returning to annual screening, whereas those showing atypia (with or without radial scar) on CNB were recommended to undergo surgical excision; however, patients could electively undergo the alternative management option. Malignancy rates were assessed, considering ADs to be nonmalignant based on results of repeat CNB, surgical excision, or 12-month diagnostic imaging follow-up. RESULTS. The final sample included 106 patients (mean age, 58 years) with 109 ADs meeting selection criteria and that underwent repeat CNB, surgical excision, or 12 months of diagnostic imaging follow-up. The malignancy rate was 0% (0/58) for ADs showing benign pathology on CNB (49 with imaging surveillance, two with repeat CNB, seven with excision), 0% (0/36) for ADs showing radial scar without atypia on CNB (22 with imaging surveillance, 14 with excision), 10% (1/10) for ADs showing radial scar with atypia on CNB (all with excision), and 40% (2/5) for ADs showing atypia without radial scar on CNB (two with imaging surveillance, three with excision). Overall, the malignancy rate was 0% (0/94) versus 20% (3/15) in the absence versus presence, respectively, of atypia (with or without radial scar) on CNB. CONCLUSION. The malignancy rate was 0% for ADs without atypia, versus 20% for ADs with atypia, on CNB. CLINICAL IMPACT. Imaging surveillance may be a safe alternative to surgical excision for ADs detected by DBT alone with no ultrasound correlate showing benign pathology without atypia on CNB.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Nguyen DL, Langman EL, Johnson KS, et al. Architectural Distortions Detected by DBT Alone With No Ultrasound Correlate and Nonmalignant Results on Core Needle Biopsy: Outcomes From an Imaging-Focused Management Strategy. AJR Am J Roentgenol. 2025. PMID: 40071902. doi:10.2214/AJR.25.32737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。